Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04993859

Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children

Status
Recruiting
Phase
Study type
Observational
Enrollment
152 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
5 Years – 13 Years
Healthy volunteers
Not accepted

Summary

The over-arching aim of this study is to evaluate the effects of two specific anti-cancer chemotherapies, vincristine and doxorubicin, on bladder function and urine composition.

Detailed description

The over-arching aim of this study is to evaluate the effects of two specific anti-cancer chemotherapies, vincristine and doxorubicin, on bladder function and urine composition. The global hypothesis is that childhood cancer survivors with prior exposure to systemic vincristine (VCR) and/or doxorubicin (DOX) report an increased incidence of bladder dysfunction (BD) symptoms on the Dysfunctional Voiding Symptom Score (DVSS) survey. We expect to observe differences in non-invasive urodynamic (niUDS) testing between childhood cancer survivors with BD symptoms on the DVSS versus those without BD symptoms on DVSS. We also expect to observe statistically significant differences in the urinary levels of known urinary biomarkers of BD (NGF, ATP and BDNF) of patients with evidence of BD compared to those without BD on the DVSS. We also expect to observe rational differences in the urinary proteome of patients between those with and without BD.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNon-invasive Urodynamic Test (niUDS)A noninvasive urodynamics is a simple test used to evaluate urinary flow.
DIAGNOSTIC_TESTUrinary proteomic screenUrine proteomics is a powerful platform to identify urinary excreted proteins and peptides in different stages of disease or therapy and to determine their quantity, functions, and interaction.
OTHERDysfunctional Voiding Symptom Score Survey (DVSS)The Dysfunctional Voiding Symptom Score provides accurate and objective grading of voiding behaviors of children.

Timeline

Start date
2021-06-02
Primary completion
2026-07-09
Completion
2026-07-09
First posted
2021-08-06
Last updated
2025-10-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04993859. Inclusion in this directory is not an endorsement.